Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Follow-Up Questions
Who is the CEO of Azenta Inc?
Mr. John Marotta is the President of Azenta Inc, joining the firm since 2024.
What is the price performance of AZTA stock?
The current price of AZTA is $30.85, it has decreased 0.38% in the last trading day.
What are the primary business themes or industries for Azenta Inc?
Azenta Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Azenta Inc market cap?
Azenta Inc's current market cap is $1.4B
Is Azenta Inc a buy, sell, or hold?
According to wall street analysts, 9 analysts have made analyst ratings for Azenta Inc, including 2 strong buy, 5 buy, 6 hold, 1 sell, and 2 strong sell
